Both our sci-ATAC-seq data and our cyclic IF results indicate NRXN1 and NLGN1 expression in immune cells infiltrating the prostate tumours (Supplementary Fig. 4A and Fig. 5d, e). Here, NRXN1 is linked to prostate neoplasm.